BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Jeremy Shapiro , Jeanne Tie , Jeanne Tie , Louise Nott
Targeted Oncology 16 ( 2) 227 -236
2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
Jeremy Shapiro , Richard de Boer , Sheau Wen Lok , Sheau Wen Lok
International Journal of Cancer 149 ( 2) 409 -419
2021
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.
Wassim Abida , Akash Patnaik , David Campbell , Jeremy Shapiro
Journal of Clinical Oncology 38 ( 32) 3763 -3772
362
2020
Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study.
Natasha Michael , Greta Beale , Clare O’Callaghan , Adelaide Melia
BMC Palliative Care 18 ( 1) 13 -13
10
2019
Measurement of plasma uracil using gas chromatography-mass spectrometry in normal individuals and in patients receiving inhibitors of dihydropyrimidine dehydrogenase.
Daoqin Bi , Lawrence W. Anderson , Jeremy Shapiro , Alla Shapiro
Journal of Chromatography B: Biomedical Sciences and Applications 738 ( 2) 249 -258
28
2000
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma
Anthony J. Gill , Lara Lipton , Jessica Taylor , Diane E. Benn
Pathology 45 ( 7) 689 -691
58
2013
Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia
Sagun Parakh , Hui-Li Wong , Rajat Rai , Sayed Ali
Journal of Geriatric Oncology 6 ( 5) 387 -394
14
2015
Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres
Matthew Grant , Andrew Haydon , Lewis Au , Simon Wilkins
International Journal of Surgery 51 71 -75
3
2018
Hyponatremia of malignancy
Jeremy Shapiro , Gary E. Richardson
Critical Reviews in Oncology Hematology 18 ( 2) 129 -135
12
1995
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
Eva Segelov , Paul Waring , Jayesh Desai , Kate Wilson
BMC Cancer 16 ( 1) 339 -339
11
2016
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.
Monica Tang , Timothy Jay Price , Jeremy Shapiro , Peter Gibbs
Expert Review of Anticancer Therapy 18 ( 4) 339 -349
4
2018
Targeted therapy for metastatic colorectal cancer
Timothy J. Price , Monica Tang , Peter Gibbs , Daniel G. Haller
Expert Review of Anticancer Therapy 18 ( 10) 991 -1006
47
2018
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Amitesh C Roy , Jeremy Shapiro , Matt Burge , Christos S Karapetis
Expert Review of Anticancer Therapy 20 ( 4) 305 -324
2020
Primary tumor resection in metastatic colorectal cancer (mCRC): A prospective cohort study.
Shu Fen Wong , Kathryn M Field , Suzanne Kosmider , Jeanne Tie
Journal of Clinical Oncology 31 ( 15) 3584 -3584
2013
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Christine Semira , Hui‐Li Wong , Kathryn Field , Margaret Lee
Internal Medicine Journal 49 ( 4) 446 -454
6
2019
Dose modification for haematological toxicity: a survey of Australian medical oncologists
Wanyuan Cui , Julia Shingleton , Liesel Byrne , Aisling Kelly
Internal Medicine Journal 50 ( 11) 1338 -1343
2020
A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.
Michael Jefford , Karla Gough , Allison Drosdowsky , Lahiru Russell
Oncologist 21 ( 8) 1014 -1023
65
2016
Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
David L. Chan , Nick Pavlakis , Jeremy Shapiro , Timothy J. Price
PLOS ONE 10 ( 9) e0138916
5
2015
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
Derek J Jonker , Louise Nott , Takayuki Yoshino , Sharlene Gill
The Lancet Gastroenterology & Hepatology 3 ( 4) 263 -270
55
2018
Australian contemporary management of synchronous metastatic colorectal cancer
Phillip Malouf , Peter Gibbs , Jeremy Shapiro , Jim Sockler
Anz Journal of Surgery 88 71 -76
2018